ARCHIVES

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

This article is from The Cancer Letter archive.

Vol. 40 No. 05 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Raymond Weiss Reviews Confidential Report on I-ELCAP

April 29, 2011

Funding opportunities listed.

June 4, 2004

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013